EKF Diagnostics (LON:EKF) Stock Crosses Above 200-Day Moving Average - Should You Sell?

Key Points

• EKF Diagnostics shares have surpassed their 200-day moving average, trading as high as GBX 29.80 ($0.40).
• The company reported a market capitalization of £132.45 million and a P/E ratio of 27.73.
• EKF specializes in Point-of-Care analysers and Life Sciences services, with operations in over 120 countries globally.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 24.27 ($0.33) and traded as high as GBX 29.80 ($0.40). EKF Diagnostics shares last traded at GBX 29.80 ($0.40), with a volume of 38,681 shares traded.

EKF Diagnostics Stock Up 4.2%

The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The company's 50-day simple moving average is GBX 27.33 and its 200 day simple moving average is GBX 24.31. The firm has a market cap of £120.01 million, a P/E ratio of 25.13 and a beta of 0.57.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.